Establishment of Online Registration Platform for Unruptured Intracranial Aneurysms Based on 100 Regional Medical Centers in China and Population Follow-up Study
1 other identifier
observational
1,000
1 country
1
Brief Summary
In this study, 20 regional neurosurgery centers across the country will be included, and the study cohort will be constructed on the basis of the IARP-CP cohort.The artificial intelligence platform was used to analyze the clinical, morphological, hemodynamics, aneurysm wall characteristics and other factors of unruptured aneurysms, as well as the relationship between these factors and the risk of aneurysm instability, seek the potential risk factors, and finally establish a multi-dimensional prediction model of rupture risk of intracranial aneurysms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2021
CompletedFirst Posted
Study publicly available on registry
May 5, 2021
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2022
CompletedNovember 8, 2022
November 1, 2022
6 months
April 22, 2021
November 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Aneurysm rupture
2 years
Secondary Outcomes (1)
Aneurysm growth
2 years
Study Arms (2)
unstable intracranial aneurysms
Unstable intracranial aneurysms are defined as the intracranial aneurysms that grows or ruptures.
stable intracranial aneurysms
Stable intracranial aneurysms are defined as the intracranial aneurysms that have no significant morphological changes.
Interventions
This study is an observational study without any intervention
Eligibility Criteria
Chinese
You may qualify if:
- years old;
- At least one unruptured intracranial aneurysm was found by CTA;
- No relevant symptoms, receiving non-operative and conservative observation treatment;
- Signing the informed consent.
You may not qualify if:
- Other cerebrovascular structural lesions (such as cerebrovascular malformation and arteriovenous fistula) or craniocerebral tumors;
- Fusiform or dissecting aneurysms;
- Traumatic, mycotic and atrial myxoma associated aneurysms;
- Suffering from systemic connective tissue diseases, such as polycystic kidney disease;
- Expectant survival of no more than 3 years due to other diseases or poor general conditions;
- Patients refuse to follow up or cannot communicate with them due to mental diseases;
- Pregnant women or participating in other aneurysm related studies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beijing Tiantan Hospitallead
- Beijing Hospitalcollaborator
- Peking University Third Hospitalcollaborator
- Beijing Sanbo Brain Hospitalcollaborator
- Beijing Chao Yang Hospitalcollaborator
- Binzhou Renmin Hospitalcollaborator
- Fujian Medical University Union Hospitalcollaborator
- First Affiliated Hospital of Fujian Medical Universitycollaborator
- Guangzhou Red Cross Hospitalcollaborator
- The First Affiliated Hospital of Haerbin Medical Universitycollaborator
- The Affiliated Hospital of Qingdao Universitycollaborator
- Shanxi Provincial People's Hospitalcollaborator
- Beijing Tsinghua Changgeng Hospitalcollaborator
- RenJi Hospitalcollaborator
- Sichuan Provincial People's Hospitalcollaborator
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technologycollaborator
- The Affiliated Hospital of Kunming Medical Universitycollaborator
- Beijing Unimed Technology Companycollaborator
Study Sites (1)
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China
Related Publications (1)
Liu Q, Li J, Zhang Y, Leng X, Mossa-Basha M, Levitt MR, Wang S, Zhu C. Association of calcium channel blockers with lower incidence of intracranial aneurysm rupture and growth in hypertensive patients. J Neurosurg. 2023 Jan 27;139(3):651-660. doi: 10.3171/2022.12.JNS222428. Print 2023 Sep 1.
PMID: 36708539DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shuo Wang, MD
Beijing Tiantan Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Department of Cerebrovascular Neurosurgery
Study Record Dates
First Submitted
April 22, 2021
First Posted
May 5, 2021
Study Start
September 1, 2021
Primary Completion
March 1, 2022
Study Completion
May 1, 2022
Last Updated
November 8, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will share